deltatrials
Completed PHASE1 INTERVENTIONAL NCT00033215

A Phase 1 Study of S-3304 in Patients With Solid Tumors

Sponsor: Shionogi

Conditions Solid Tumors
Interventions S-3304
Updated 6 times since 2017 Last updated: Apr 24, 2018 Started: Nov 30, 2001 Primary completion: Feb 13, 2003 Completion: Mar 12, 2003
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00033215, this PHASE1 trial focuses on Solid Tumors and remains completed. Sponsored by Shionogi, it has been updated 6 times since 2001, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~May 2018 · 16 months · monthly snapshotUnknown Status~May 2018 – ~Jun 2018 · 31 days · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. May 2018 — Jun 2018 [monthly]

    Completed PHASE1

    Status: Unknown Status → Completed

▶ Show 1 earlier version

  1. Jan 2017 — May 2018 [monthly]

    Unknown Status PHASE1

    First recorded

Nov 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shionogi
Data source: Shionogi Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations